About Us
MEDIAN Technologies has developed Lesion Management Solutions — LMS ― to objectively measure and track cancerous or suspicious lesions, distribute a standardized oncologic report and centralize the lesion information for multidisciplinary review.
Cancer patient management today is multidisciplinary and MEDIAN LMS is routinely used because all specialists involved need quantitative, objective and standardized reports to provide the best quality of care to their patients. MEDIAN LMS is also used in multicentric clinical trials that need standardized lesion measurements and reporting according to criteria such as RECIST to assess drug effectiveness.
MEDIAN LMS contributes to better quality of care for cancer patients:
- Objective evaluation of lesions and lesion growth
- Enhanced communication among specialists during tumor boards and multi-disciplinary staff meetings
- Efficient oncology imaging reporting in clinical routine and clinical trials
- Easier management of lesion information in multi-site configurations